Carlo Incerti - Mar 2, 2022 Form 3 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
3
Date filed
3/4/2022, 05:21 PM
Next filing
May 25, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.